PDS Biotechnology (PDSB) Prepaid Assets (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Prepaid Assets came in at $1.5 million in Q4 2025, down 54.17% YoY from $3.4 million in Q4 2024, and down 8.98% on a QoQ basis from $1.7 million in Q3 2025.
PDS Biotechnology (PDSB) Prepaid Assets (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 12 years of Prepaid Assets data on file, last reported at $1.5 million in Q4 2025.
- Quarterly Prepaid Assets fell 54.17% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 54.17% YoY) and the FY2025 annual result came in at $1.5 million, down 54.17% from the prior year.
- Prepaid Assets declined to $1.5 million in Q4 2025, from $1.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.4 million in Q4 2024 to a low of $1.5 million in Q4 2025.
- A 5-year average of $2.3 million and a median of $2.4 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets soared 327.65% — and 2025, when it slumped 54.17%.
- Tracing PDSB's Prepaid Assets over 5 years: stood at $1.6 million in 2021, then surged by 66.52% to $2.7 million in 2022, then slipped by 6.23% to $2.5 million in 2023, then soared by 34.89% to $3.4 million in 2024, then tumbled by 54.17% to $1.5 million in 2025.
- The last three Prepaid Assets figures came in at $1.5 million (Q4 2025), $1.7 million (Q3 2025), and $1.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.45 Mn |
| Dec 31, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.77 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | 3.36 Mn |
| Sep 30, 2024 | 2.38 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Mar 31, 2024 | 2.05 Mn |
| Dec 31, 2023 | 2.49 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 2.73 Mn |
| Mar 31, 2023 | 2.77 Mn |
| Dec 31, 2022 | 2.66 Mn |
| Sep 30, 2022 | 2.77 Mn |
| Jun 30, 2022 | 2.76 Mn |
| Mar 31, 2022 | 1.85 Mn |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 2.19 Mn |